El año pasado, AstraZeneca PLC generó 8.40B USD en su segmento con mejor rendimiento, Farxiga. United States realizó la mayor aportación, representando 23.97B USD el año pasado. Para el último trimestre, AstraZeneca PLC reportó unos ingresos de 61.02B USD para el periodo finalizado el 2026-06-30, procedentes del segmento con mejor rendimiento, Calquenc. United States aportó los mayores ingresos, alcanzando los 6.68B USD.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Farxiga

Tagrisso

Imfinzi

Ultomiris

Calquenc

Lynparza

Symbicort

Fasenra

Soliris

Strensiq

Crestor

Breztri

Zoladex

Enhertu

Brilinta

Nexium

Truqap

Lokelma

Saphnelo

Koselugo

Seloken/Toprol-XL

BioPharmaceuticals: CVRM Others

Pulmicort

Tezspire

Oncology Others

Imjudo

Synagis

Beyfortus

BioPharmaceuticals: Respiratory & Immunology Others

Roxadustat

FluMist

rare disease - Other

Wainua

Airsupra

Other medicines others

Datroway

Vaccines & Immune Therapies Others

Andexxa

Kanuma

Orpathys

COVID-19 mAbs

Vaxzevria

Faslodex

Onglyza

Bydureon

Bevespi

Daliresp/Daxas Bevespi

Evusheld

Iressa

Arimidex

Casodex

Covid

Losec/Prilosec

Atacand

Seroquel XR/IR

Other diabetes

Byetta

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Farxiga

8.40B(15.12%)

7.66B(15.03%)

5.96B(13.62%)

4.38B(10.19%)

3.00B(8.21%)

1.96B(7.57%)

Tagrisso

7.25B(13.05%)

6.58B(12.92%)

5.80B(13.24%)

5.44B(12.66%)

5.01B(13.72%)

4.33B(16.72%)

Imfinzi

6.06B(10.91%)

4.72B(9.26%)

4.24B(9.68%)

2.78B(6.47%)

2.41B(6.60%)

2.04B(7.89%)

Ultomiris

4.72B(8.49%)

3.92B(7.70%)

2.96B(6.77%)

1.97B(4.57%)

688.00M(1.88%)

--(--)

Calquenc

3.52B(6.33%)

3.13B(6.14%)

2.51B(5.74%)

2.06B(4.78%)

1.24B(3.39%)

522.00M(2.02%)

Lynparza

3.28B(5.90%)

3.07B(6.03%)

2.81B(6.42%)

2.64B(6.14%)

2.35B(6.43%)

1.78B(6.86%)

Symbicort

2.88B(5.19%)

2.88B(5.65%)

2.36B(5.39%)

2.54B(5.90%)

2.73B(7.47%)

2.72B(10.51%)

Fasenra

1.98B(3.56%)

1.69B(3.32%)

1.55B(3.55%)

1.40B(3.25%)

1.26B(3.44%)

949.00M(3.67%)

Soliris

1.84B(3.31%)

2.59B(5.08%)

3.15B(7.18%)

3.76B(8.75%)

1.87B(5.13%)

--(--)

Strensiq

1.68B(3.02%)

1.42B(2.78%)

1.15B(2.63%)

958.00M(2.23%)

378.00M(1.03%)

--(--)

Crestor

1.22B(2.19%)

1.15B(2.26%)

1.11B(2.53%)

1.05B(2.44%)

1.10B(3.00%)

1.18B(4.56%)

Breztri

1.20B(2.16%)

978.00M(1.92%)

677.00M(1.55%)

398.00M(0.93%)

203.00M(0.56%)

28.00M(0.11%)

Zoladex

1.11B(1.99%)

1.06B(2.08%)

952.00M(2.17%)

927.00M(2.16%)

948.00M(2.59%)

888.00M(3.43%)

Enhertu

977.00M(1.76%)

545.00M(1.07%)

261.00M(0.60%)

79.00M(0.18%)

17.00M(0.05%)

--(--)

Brilinta

823.00M(1.48%)

1.33B(2.62%)

1.32B(3.02%)

1.36B(3.16%)

1.47B(4.03%)

1.59B(6.15%)

Nexium

816.00M(1.47%)

867.00M(1.70%)

945.00M(2.16%)

1.28B(2.99%)

1.33B(3.63%)

1.49B(5.76%)

Truqap

728.00M(1.31%)

430.00M(0.84%)

6.00M(0.01%)

--(--)

Lokelma

698.00M(1.26%)

542.00M(1.06%)

412.00M(0.94%)

289.00M(0.67%)

175.00M(0.48%)

76.00M(0.29%)

Saphnelo

686.00M(1.23%)

467.00M(0.92%)

278.00M(0.63%)

116.00M(0.27%)

8.00M(0.02%)

--(--)

Koselugo

662.00M(1.19%)

531.00M(1.04%)

331.00M(0.76%)

208.00M(0.48%)

108.00M(0.30%)

38.00M(0.15%)

Seloken/Toprol-XL

607.00M(1.09%)

605.00M(1.19%)

640.00M(1.46%)

862.00M(2.00%)

951.00M(2.60%)

821.00M(3.17%)

BioPharmaceuticals: CVRM Others

534.00M(0.96%)

524.00M(1.03%)

296.00M(0.68%)

366.00M(0.85%)

196.00M(0.54%)

191.00M(0.74%)

Pulmicort

518.00M(0.93%)

682.00M(1.34%)

713.00M(1.63%)

645.00M(1.50%)

962.00M(2.63%)

996.00M(3.85%)

Tezspire

458.00M(0.82%)

248.00M(0.49%)

85.00M(0.19%)

4.00M(0.01%)

--(--)

Oncology Others

425.00M(0.76%)

419.00M(0.82%)

224.00M(0.51%)

44.00M(0.10%)

50.00M(0.14%)

51.00M(0.20%)

Imjudo

346.00M(0.62%)

281.00M(0.55%)

--(--)

Synagis

292.00M(0.53%)

447.00M(0.88%)

546.00M(1.25%)

578.00M(1.34%)

410.00M(1.12%)

372.00M(1.44%)

Beyfortus

281.00M(0.51%)

316.00M(0.62%)

106.00M(0.24%)

--(--)

BioPharmaceuticals: Respiratory & Immunology Others

274.00M(0.49%)

400.00M(0.79%)

324.00M(0.74%)

421.00M(0.98%)

594.00M(1.63%)

398.00M(1.54%)

Roxadustat

274.00M(0.49%)

331.00M(0.65%)

271.00M(0.62%)

197.00M(0.46%)

174.00M(0.48%)

--(--)

FluMist

272.00M(0.49%)

258.00M(0.51%)

216.00M(0.49%)

175.00M(0.41%)

253.00M(0.69%)

295.00M(1.14%)

rare disease - Other

231.00M(0.42%)

--(--)

Wainua

212.00M(0.38%)

85.00M(0.17%)

--(--)

Airsupra

166.00M(0.30%)

66.00M(0.13%)

--(--)

Other medicines others

156.00M(0.28%)

206.00M(0.40%)

231.00M(0.53%)

340.00M(0.79%)

106.00M(0.29%)

128.00M(0.49%)

Datroway

2.00M(--)

--(--)

Vaccines & Immune Therapies Others

1.00M(--)

4.00M(0.01%)

--(--)

Andexxa

--(--)

219.00M(0.43%)

182.00M(0.42%)

150.00M(0.35%)

68.00M(0.19%)

--(--)

Kanuma

--(--)

209.00M(0.41%)

171.00M(0.39%)

160.00M(0.37%)

62.00M(0.17%)

--(--)

Orpathys

--(--)

44.00M(0.09%)

44.00M(0.10%)

33.00M(0.08%)

16.00M(0.04%)

--(--)

COVID-19 mAbs

--(--)

31.00M(0.06%)

132.00M(0.30%)

--(--)

Vaxzevria

--(--)

4.00M(0.01%)

12.00M(0.03%)

1.80B(4.18%)

--(--)

Faslodex

--(--)

297.00M(0.68%)

334.00M(0.78%)

431.00M(1.18%)

580.00M(2.24%)

Onglyza

--(--)

227.00M(0.52%)

257.00M(0.60%)

360.00M(0.99%)

470.00M(1.82%)

Bydureon

--(--)

163.00M(0.37%)

280.00M(0.65%)

385.00M(1.05%)

448.00M(1.73%)

Bevespi

--(--)

58.00M(0.13%)

54.00M(0.15%)

48.00M(0.19%)

Daliresp/Daxas Bevespi

--(--)

54.00M(0.12%)

189.00M(0.44%)

227.00M(0.62%)

217.00M(0.84%)

Evusheld

--(--)

2.19B(5.08%)

--(--)

Iressa

--(--)

114.00M(0.27%)

183.00M(0.50%)

268.00M(1.04%)

Arimidex

--(--)

99.00M(0.23%)

139.00M(0.38%)

185.00M(0.71%)

Casodex

--(--)

78.00M(0.18%)

143.00M(0.39%)

172.00M(0.66%)

Covid

--(--)

4.00B(10.95%)

--(--)

Losec/Prilosec

--(--)

180.00M(0.49%)

183.00M(0.71%)

Atacand

--(--)

97.00M(0.27%)

243.00M(0.94%)

Seroquel XR/IR

--(--)

92.00M(0.25%)

117.00M(0.45%)

Other diabetes

--(--)

59.00M(0.16%)

47.00M(0.18%)

Byetta

--(--)

55.00M(0.15%)

68.00M(0.26%)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

United States

China

United Kingdom

Other European Countries

Japan

Germany

Other Asia, Africa & Australasia

Central America/Other South American Countries

Sweden

France

Spain

Italy

Canada

Australia

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

23.97B(40.81%)

21.81B(40.33%)

18.12B(39.56%)

17.28B(38.96%)

12.05B(32.20%)

8.96B(33.64%)

8.05B(33.00%)

China

6.64B(11.30%)

6.42B(11.87%)

5.87B(12.82%)

5.74B(12.95%)

6.00B(16.04%)

5.34B(20.08%)

4.87B(19.96%)

United Kingdom

4.36B(7.42%)

4.74B(8.77%)

3.37B(7.35%)

3.12B(7.03%)

3.25B(8.67%)

1.74B(6.54%)

1.82B(7.47%)

Other European Countries

4.32B(7.35%)

3.66B(6.77%)

3.11B(6.79%)

2.71B(6.10%)

1.95B(5.21%)

1.39B(5.23%)

1.29B(5.29%)

Japan

3.56B(6.05%)

3.45B(6.38%)

3.64B(7.95%)

3.99B(8.99%)

3.40B(9.07%)

2.57B(9.64%)

2.52B(10.34%)

Germany

2.89B(4.92%)

2.52B(4.67%)

2.10B(4.58%)

1.90B(4.29%)

1.49B(3.97%)

937.00M(3.52%)

704.00M(2.89%)

Other Asia, Africa & Australasia

2.72B(4.63%)

2.33B(4.31%)

2.04B(4.46%)

2.41B(5.42%)

2.38B(6.36%)

1.53B(5.76%)

1.42B(5.82%)

Central America/Other South American Countries

2.63B(4.48%)

2.25B(4.15%)

1.68B(3.67%)

1.18B(2.65%)

1.20B(3.22%)

761.00M(2.86%)

814.00M(3.34%)

Sweden

2.62B(4.47%)

2.29B(4.24%)

1.70B(3.72%)

1.72B(3.88%)

2.32B(6.21%)

1.03B(3.85%)

834.00M(3.42%)

France

1.41B(2.40%)

1.28B(2.37%)

1.15B(2.51%)

1.11B(2.50%)

915.00M(2.45%)

653.00M(2.45%)

578.00M(2.37%)

Spain

1.14B(1.93%)

994.00M(1.84%)

847.00M(1.85%)

738.00M(1.66%)

578.00M(1.54%)

398.00M(1.50%)

359.00M(1.47%)

Italy

1.08B(1.84%)

949.00M(1.76%)

813.00M(1.77%)

735.00M(1.66%)

577.00M(1.54%)

431.00M(1.62%)

396.00M(1.62%)

Canada

954.00M(1.62%)

937.00M(1.73%)

967.00M(2.11%)

1.17B(2.63%)

772.00M(2.06%)

596.00M(2.24%)

466.00M(1.91%)

Australia

454.00M(0.77%)

439.00M(0.81%)

390.00M(0.85%)

571.00M(1.29%)

547.00M(1.46%)

282.00M(1.06%)

266.00M(1.09%)